ANRO R&D Expenses
Alto Neuroscience, Inc. Common Stock · R&D Expenses
ANRO R&D Expenses
Latest reported$64.92Mperiod ending
ANRO R&D Expenses ($8.37M → $64.92M)
Annual R&D Expenses
High-resolution chart · PNG
ANRO r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 45,619,000 | |
| 46,996,000 | |
| 30,291,000 | |
| 23,688,000 | |
| 8,370,000 |